title: Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity.
abstract: Visceral adipose tissue (VAT) is an important risk factor for obesity-related metabolic disorders. Therefore, a reduction in VAT has become a key goal in obesity management. However, VAT is correlated with intrahepatic triglyceride (IHTG) content, so it is possible that IHTG, not VAT, is a better marker of metabolic disease. We determined the independent association of IHTG and VAT to metabolic function, by evaluating groups of obese subjects, who differed in IHTG content (high or normal) but matched on VAT volume or differed in VAT volume (high or low) but matched on IHTG content. Stable isotope tracer techniques and the euglycemic-hyperinsulinemic clamp procedure were used to assess insulin sensitivity and very-low-density lipoprotein-triglyceride (VLDL-TG) secretion rate. Tissue biopsies were obtained to evaluate cellular factors involved in ectopic triglyceride accumulation. Hepatic, adipose tissue and muscle insulin sensitivity were 41, 13, and 36% lower (P < 0.01), whereas VLDL-triglyceride secretion rate was almost double (P < 0.001), in subjects with higher than normal IHTG content, matched on VAT. No differences in insulin sensitivity or VLDL-TG secretion were observed between subjects with different VAT volumes, matched on IHTG content. Adipose tissue CD36 expression was lower (P < 0.05), whereas skeletal muscle CD36 expression was higher (P < 0.05), in subjects with higher than normal IHTG. These data demonstrate that IHTG, not VAT, is a better marker of the metabolic derangements associated with obesity. Furthermore, alterations in tissue fatty acid transport could be involved in the pathogenesis of ectopic triglyceride accumulation by redirecting plasma fatty acid uptake from adipose tissue toward other tissues.
authors.affiliation: Center for Human Nutrition and Atkins Center of Excellence in Obesity Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA.
authors.forename: Elisa
authors.initials: E
authors.lastname: Fabbrini
authors.forename: Faidon
authors.initials: F
authors.lastname: Magkos
authors.forename: B Selma
authors.initials: BS
authors.lastname: Mohammed
authors.forename: Terri
authors.initials: T
authors.lastname: Pietka
authors.forename: Nada A
authors.initials: NA
authors.lastname: Abumrad
authors.forename: Bruce W
authors.initials: BW
authors.lastname: Patterson
authors.forename: Adewole
authors.initials: A
authors.lastname: Okunade
authors.forename: Samuel
authors.initials: S
authors.lastname: Klein
mesh_terms: D001823:Body Composition; D018955:CD36 Antigens / Q000378:metabolism; D017931:DNA Primers; D005260:Female; D005947:Glucose / Q000378:metabolism; D015309:Glucose Clamp Technique; D006801:Humans; D050152:Intra-Abdominal Fat / Q000378:metabolism / Q000473:pathology; D008079:Lipoproteins, VLDL / Q000032:analysis; D008099:Liver / Q000737:chemistry*; D008297:Male; D008659:Metabolic Diseases / Q000209:etiology*; D009765:Obesity / Q000150:complications*; D010168:Palmitates / Q000378:metabolism; D020133:Reverse Transcriptase Polymerase Chain Reaction; D014280:Triglycerides / Q000032:analysis*
chemical_list: D018955:CD36 Antigens; D017931:DNA Primers; D008079:Lipoproteins, VLDL; D010168:Palmitates; D014280:Triglycerides; D005947:Glucose
references.citation: J Lipid Res. 2009 Apr;50 Suppl:S86-90
references.pmid: 19033209
references.citation: N Engl J Med. 2004 Jun 17;350(25):2549-57
references.pmid: 15201411
references.citation: J Biol Chem. 2001 Nov 2;276(44):40567-73
references.pmid: 11504711
references.citation: Gastroenterology. 2007 Jan;132(1):282-93
references.pmid: 17241878
references.citation: J Clin Invest. 2000 Jul;106(2):171-6
references.pmid: 10903330
references.citation: J Clin Endocrinol Metab. 2002 Nov;87(11):5098-103
references.pmid: 12414878
references.citation: J Lipid Res. 2002 Feb;43(2):223-33
references.pmid: 11861664
references.citation: Nat Med. 2001 Aug;7(8):947-53
references.pmid: 11479628
references.citation: Diabetes Care. 2002 Mar;25(3):431-8
references.pmid: 11874926
references.citation: J Clin Invest. 2003 Jul;112(1):91-100
references.pmid: 12840063
references.citation: Nat Med. 2001 Aug;7(8):941-6
references.pmid: 11479627
references.citation: J Clin Invest. 2005 May;115(5):1343-51
references.pmid: 15864352
references.citation: J Cardiometab Syndr. 2007 Spring;2(2):136-8
references.pmid: 17684473
references.citation: Obes Res. 1998 Apr;6 Suppl 1:8S-17S
references.pmid: 9569171
references.citation: Am J Physiol Endocrinol Metab. 2005 Feb;288(2):E462-8
references.pmid: 15339742
references.citation: J Clin Endocrinol Metab. 2003 Nov;88(11):5444-51
references.pmid: 14602787
references.citation: J Clin Invest. 1995 Jan;95(1):158-66
references.pmid: 7814610
references.citation: Biochim Biophys Acta. 2005 Oct 1;1736(3):163-80
references.pmid: 16198626
references.citation: J Lipid Res. 2007 May;48(5):1204-11
references.pmid: 17325388
references.citation: J Clin Endocrinol Metab. 2007 Feb;92(2):720-4
references.pmid: 17148569
references.citation: Obesity (Silver Spring). 2006 Feb;14 Suppl 1:16S-19S
references.pmid: 16642958
references.citation: Gastroenterology. 2008 Feb;134(2):424-31
references.pmid: 18242210
references.citation: N Engl J Med. 2006 Nov 30;355(22):2297-307
references.pmid: 17135584
references.citation: Nature. 2006 Dec 14;444(7121):881-7
references.pmid: 17167477
references.citation: Am J Physiol Gastrointest Liver Physiol. 2008 May;294(5):G1281-7
references.pmid: 18388185
references.citation: Diabetes. 2001 Aug;50(8):1844-50
references.pmid: 11473047
references.citation: J Biol Chem. 2008 May 16;283(20):13578-85
references.pmid: 18353783
references.citation: Am J Physiol Endocrinol Metab. 2003 Mar;284(3):E549-56
references.pmid: 12475754
references.citation: J Clin Invest. 2004 Jul;114(2):147-52
references.pmid: 15254578
references.citation: Am J Physiol. 1956 Sep;187(1):15-24
references.pmid: 13362583
references.citation: J Clin Invest. 2007 Sep;117(9):2621-37
references.pmid: 17717599
references.citation: Diabetes. 2007 Jul;56(7):1872-80
references.pmid: 17440173
references.citation: FASEB J. 2004 Jul;18(10):1144-6
references.pmid: 15132977
references.citation: J Clin Invest. 2004 Jun;113(11):1530-2
references.pmid: 15173878
references.citation: Endocrinol Metab Clin North Am. 2008 Sep;37(3):635-46, viii-ix
references.pmid: 18775356
references.citation: Biochemistry. 2004 Apr 13;43(14):4179-87
references.pmid: 15065861
references.citation: Am J Physiol Endocrinol Metab. 2006 Feb;290(2):E355-62
references.pmid: 16219668
references.citation: Diabetes Care. 1999 Sep;22(9):1462-70
references.pmid: 10480510
references.citation: J Lipid Res. 1999 Nov;40(11):2118-24
references.pmid: 10553015
references.citation: Int J Obes Relat Metab Disord. 2004 Dec;28 Suppl 4:S12-21
references.pmid: 15592481
references.citation: Epidemiol Rev. 2007;29:77-87
references.pmid: 17478441
references.citation: J Clin Invest. 2004 Jun;113(11):1582-8
references.pmid: 15173884
references.citation: Diabetologia. 2006 Apr;49(4):755-65
references.pmid: 16463046
references.citation: Diabetes. 2002 Oct;51(10):3113-9
references.pmid: 12351456
references.citation: Diabetes. 2007 Apr;56(4):1010-3
references.pmid: 17287468
references.citation: Diabetes Metab. 2003 Nov;29(5):478-85
references.pmid: 14631324
references.citation: BMC Cell Biol. 2008 Aug 13;9:45
references.pmid: 18700980
references.citation: Acta Physiol (Oxf). 2007 Jul;190(3):209-19
references.pmid: 17394567
references.citation: Am J Physiol Endocrinol Metab. 2007 Dec;293(6):E1663-9
references.pmid: 17911339
references.citation: J Clin Endocrinol Metab. 2006 Nov;91(11):4459-66
references.pmid: 16926254
references.citation: Gastroenterology. 2008 May;134(5):1369-75
references.pmid: 18355813